12. Restatement (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Dec. 31, 2011
Inventory	$ 167,165		$ 167,165		$ 161,349
Stock settlement payable	124,578	124,578	124,578	124,578	124,578
Stock settlement in process	124,578		124,578		124,578
Revenue	209,775	187,693	564,756	281,525
Cost of sales	50,567	103,400	210,216	114,254
Gross profit	159,208	84,293	354,540	167,271
Operating expenses	351,347	157,136	913,636	577,827
Net Operating income (loss)	(192,139)	(72,843)	(559,096)	(410,556)
Gain from renegotiated debt		19,247		19,247
Loss on equity transactions		12,865		48,106
Interest Expense	5,650	23,327	36,920	52,832
Net loss	(197,789)	(89,788)	(596,016)	(492,247)
Original
Accounts receivable		374,028		374,028
Inventory		108,267		108,267
Total assets		1,483,571		1,483,571
Accounts payable		782,797		782,797
Stock settlement payable		0		0
Deferred income		0		0
Current liabilities		1,793,144		1,793,144
Total liabilities		1,822,865		1,822,865
Stock settlement in process		0		0
End of period		(23,206,116)		(23,206,116)
Total stockholders deficit		(339,294)		(339,294)
Revenue				576,735
Cost of sales				198,023
Gross profit				378,712
Operating expenses				575,968
Net Operating income (loss)				(197,256)
Revenue sharing				(70,135)
Gain from renegotiated debt				0
Loss on equity transactions				0
Interest Expense				(100,938)
Net loss				(368,329)
Restated
Accounts receivable		212,276		212,276
Inventory		176,716		176,716
Total assets		1,390,268		1,390,268
Accounts payable		687,764		687,764
Stock settlement payable		163,366		163,366
Deferred income		241,765		241,765
Current liabilities		2,103,242		2,103,242
Total liabilities		2,132,963		2,132,963
Stock settlement in process		163,366		163,366
End of period		(23,446,151)		(23,446,151)
Total stockholders deficit		(742,695)		(742,695)
Revenue				281,525
Cost of sales				114,254
Gross profit				167,271
Operating expenses				577,827
Net Operating income (loss)				(410,556)
Revenue sharing				0
Gain from renegotiated debt				19,247
Loss on equity transactions				(48,106)
Interest Expense				(52,832)
Net loss				(492,247)
Change
Accounts receivable		(161,752)		(161,752)
Inventory		68,449		68,449
Total assets		(93,303)		(93,303)
Accounts payable		(95,033)		(95,033)
Stock settlement payable		163,366		163,366
Deferred income		241,765		241,765
Current liabilities		310,098		310,098
Total liabilities		310,098		310,098
Stock settlement in process		163,366		163,366
End of period		(240,035)		(240,035)
Total stockholders deficit		(403,401)		(403,401)
Revenue				(295,210)
Cost of sales				(83,769)
Gross profit				(211,441)
Operating expenses				1,859
Net Operating income (loss)				(213,300)
Revenue sharing				70,135
Gain from renegotiated debt				19,247
Loss on equity transactions				(48,106)
Interest Expense				48,106
Net loss				$ (123,918)